0001808665-23-000038.txt : 20230515 0001808665-23-000038.hdr.sgml : 20230515 20230515205755 ACCESSION NUMBER: 0001808665-23-000038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230512 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peisert Daniel A. CENTRAL INDEX KEY: 0001758376 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39294 FILM NUMBER: 23925301 MAIL ADDRESS: STREET 1: C/O ASSERTIO THERAPEUTICS, INC. STREET 2: 100 SOUTH SAUNDERS ROAD, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Assertio Holdings, Inc. CENTRAL INDEX KEY: 0001808665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850598378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: (224) 419-7106 MAIL ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 4 1 wf-form4_168419864723837.xml FORM 4 X0407 4 2023-05-12 0 0001808665 Assertio Holdings, Inc. ASRT 0001758376 Peisert Daniel A. ASSERTIO HOLDINGS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045 1 1 0 0 President and CEO 0 Common Stock 2023-05-12 4 M 0 152067 0 A 464431 D Common Stock 2023-05-12 4 F 0 67365 7.65 D 397066 D Common Stock 2023-05-12 4 M 0 400000 0 A 797066 D Common Stock 2023-05-12 4 F 0 177200 7.65 D 619866 D Common Stock 2023-05-12 4 D 0 136525 7.65 D 483341 D Restricted Stock Units 0.0 2023-05-12 4 M 0 152067 0 D Common Stock 152067.0 304137 D Performance-Based Restricted Stock Units 0.0 2023-05-12 4 M 0 400000 0 D Common Stock 400000.0 0 D Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock or a combination of shares of common stock and cash. Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units. In accordance with SEC rules, the settlement of the restricted stock units for cash is reported on this Form 4 as an acquisition of the underlying common stock and a simultaneous disposition to the registrant for cash. On May 12, 2022, the reporting person was granted 456,204 restricted stock units. One-third of these restricted stock units are scheduled to vest on May 12, 2023, 2024, and 2025, assuming continued employment through the applicable vesting date. These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities. The restricted stock units were fully vested on May 12, 2023, as the trading price of the registrant's common stock exceeded certain stock price targets prior to the eighth calendar day after the registrant releases its earnings for the second quarter of 2025. After taking into effect the 177,200 shares of common stock withheld for payment of taxes, the remainder of the restricted stock unit grant was settled 136,525 shares in cash and 86,275 in shares of common stock. /s/ Sam Schlessinger, attorney-in-fact for Daniel A. Peisert 2023-05-15